These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 7853725
1. [Nicotinic acid and derivatives for therapy of hyperlipoproteinemia]. Ishikawa T. Nihon Rinsho; 1994 Dec; 52(12):3292-7. PubMed ID: 7853725 [Abstract] [Full Text] [Related]
3. The nicotinic acid receptor--a new mechanism for an old drug. Karpe F, Frayn KN. Lancet; 2004 Jun 05; 363(9424):1892-4. PubMed ID: 15183629 [Abstract] [Full Text] [Related]
4. Hyperlipidaemia and cardiovascular disease: nonantilipolytic effects of nicotinic acid in adipose tissue. Karpe F, Chamas L. Curr Opin Lipidol; 2010 Jun 05; 21(3):282-3. PubMed ID: 20463475 [No Abstract] [Full Text] [Related]
5. Effect of cyclonicate, a new hypolipemic drug, on lipolysis in vitro. Tessari F, Caparrotta L, Gaion RM, Fassina G. Farmaco Sci; 1981 Dec 05; 36(12):1029-36. PubMed ID: 6274681 [Abstract] [Full Text] [Related]
6. [Therapy of hyperlipoproteinemia]. Drexel H, Follath F. Schweiz Rundsch Med Prax; 1993 Apr 27; 82(17):506-9. PubMed ID: 8493437 [Abstract] [Full Text] [Related]
7. Nicotinic acid and its derivatives: a short survey. Hotz W. Adv Lipid Res; 1983 Apr 27; 20():195-217. PubMed ID: 6322545 [Abstract] [Full Text] [Related]
8. [Effect of combination therapy of clofibric acid and nicotinic acid derivatives on fatty acid metabolism in hyperlipoproteinemia]. Reuter W. Z Gesamte Inn Med; 1982 Oct 15; 37(20):682-8. PubMed ID: 6818779 [Abstract] [Full Text] [Related]
9. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R. Artery; 1982 Oct 15; 10(4):266-85. PubMed ID: 7181672 [Abstract] [Full Text] [Related]
10. [Clofibrate treatment of hyperlipoproteinemia]. Oikawa S, Midorikawa H. Nihon Rinsho; 1994 Dec 15; 52(12):3285-91. PubMed ID: 7853724 [Abstract] [Full Text] [Related]
11. [The mode of action of nicotinic acid on the transport of lipids]. Puglisi L, Solyom A, Usardi MM, Vertua R, Paoletti R. Pathol Biol; 1967 Feb 15; 15(3):204-8. PubMed ID: 4860731 [No Abstract] [Full Text] [Related]
12. [Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard]. Schwartzkopff W, Schilling A, Calder D. Med Welt; 1980 Apr 04; 31(14):515-20. PubMed ID: 7374415 [No Abstract] [Full Text] [Related]
13. [Hyperlipoproteinemia]. Meinders AE. Ned Tijdschr Geneeskd; 1979 Mar 14; 123(15):617-28. PubMed ID: 219378 [No Abstract] [Full Text] [Related]
15. Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism. Shepherd J, Packard CJ, Patsch JR, Gotto AM, Taunton OD. J Clin Invest; 1979 May 07; 63(5):858-67. PubMed ID: 221531 [Abstract] [Full Text] [Related]
17. [Nicotinic acid: an unjustly neglected remedy]. Zák A, Zeman M, Vecka M, Tvrzická E. Cas Lek Cesk; 2006 May 07; 145(11):825-31. PubMed ID: 17168412 [Abstract] [Full Text] [Related]
19. Current status of drugs used to treat hyperlipoproteinemias. Saunders RN, Azarnoff DL. Drug Ther; 1982 May 07; ():1-16. PubMed ID: 7049648 [No Abstract] [Full Text] [Related]
20. Current standards in diagnosis and therapy of hyperlipoproteinemia. Fischer S, Schatz U, Julius U. Atheroscler Suppl; 2013 Jan 07; 14(1):15-8. PubMed ID: 23357135 [Abstract] [Full Text] [Related] Page: [Next] [New Search]